MISTLETOE LECTIN SYNERGIZES WITH PACLITAXEL IN HUMAN SK-Hep1 HEPATOCARCINOMA CELLS

REFERENCES

• Elsasser-Beile U, Voss M, Schuhle R, Wetterauer U. Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro. J Clin Lab Anal. 2000; 14: 255
   PubMed Web of Science ®Google Scholar
• Mengs U, Schwarz T, Bulitta M, Weber K. Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice. Anticancer Res. 2000; 20: 3565
   PubMed Web of Science ®Google Scholar
• Pae H O, Seo W G, Oh G S, Shin M K, Lee H S, Lee H S, Kim S B, Chung H T. Potentiation of tumor necrosis factor-alpha-induced apoptosis by mistletoe lectin. Immunopharmacol Immunotoxicol 2000; 22: 697
   PubMed Web of Science ®Google Scholar
• Timoshenko A V, Gorudko I V, Andre S, Gabius H J. Cell-type dependence of stability modulation of lectin-initiated contacts by impairment of multivalent carbohydrate binding and intracellular signaling. Biosci Rep. 2000; 20: 199
   Google Scholar
• Park R, Kim M S, So H S, Jung B H, Moon S R, Chung S, Ko C B, Kim B, Chung H T. Activation of c-Jun N-terminal kinase 1 (JNK1) in mistletoe lectin II-induced apoptosis of human myeloleukemic U937 cells. Biochem Pharmacol. 2000; 60: 1685
   PubMed Web of Science ®Google Scholar
• Schmidt A, Mockel B, Eck J, Langer M, Gauert M, Zinke H. Cytotoxic activity of recombinant bFGF-rViscumin fusion proteins. Biochem Biophys Res Commun. 2000; 277: 499
   PubMed Web of Science ®Google Scholar
• Huber R, Barth H, Schmitt-Graff A, Klein R. Hypereosinophilia induced by high-dose intratumoral and peritumoral mistletoe application to a patient with pancreatic carcinoma. J Altern Complement Med. 2000; 6: 305
   Google Scholar
• Edlund U, Hensel A, Frose D, Pfuller U, Scheffler A. Polysaccharides from fresh Viscum album L. berry extract and their interaction with Viscum album agglutinin. I. Arzneimittelforschung 2000; 50: 645
   PubMed Web of Science ®Google Scholar
• Pae H O, Seo W G, Shin M, Lee H S, Lee H S, Kim S B, Chung H T. Protein kinase A or C modulates the apoptosis induced by lectin II isolated from Korean mistletoe, Viscum album var. Coloratum, in the human leukemic HL-60 cells. Immunopharmacol Immunotoxicol. 2000; 22: 279
   PubMed Web of Science ®Google Scholar
• Pae H O, Seo W G, Shin M, Lee H S, Lee H S, Kim S B, Chung H T. Heat shock treatment protects human HL-60 cells from apoptosis induced by lectin II isolated from Korean mistletoe, Visum album var. Coloratum. Immunopharmacol Immunotoxicol. 2000; 22: 237
   PubMed Web of Science ®Google Scholar
• Ribereau-Gayon G, Dumont S, Muller C, Jung M L, Poindron P, Anton R. Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. Cancer Lett. 1996; 109: 33
   PubMed Web of Science ®Google Scholar
• Stoffel B, Beuth J, Pulverer G. Effect of immunomodulation with galactoside- specific mistletoe lectin on experimental listeriosis. Zentralbl Bakteriol. 1996; 284: 439
   Google Scholar
• Beuth J, Stoffel B, Ko H L, Buss G, Tunggal L, Pulverer G. Immunoactive effects of various mistletoe lectin-I dosages in mammary carcinoma patients. Arzneimittelforschung 1995; 45: 505
   PubMed Web of Science ®Google Scholar
• Beuth J, Ko H L, Tunggal L, Buss G, Jeljaszewicz J, Steuer M K, Pulverer G. Immunoactive action of mistletoe lectin-I in relation to dose. Arzneimittelforschung 1994; 44: 1255
   Google Scholar
• Heiny B M, Beuth J. Mistletoe extract standardized for the galactoside-specific lectin (ML-I) induces beta-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res. 1994; 14: 1339
   PubMed Web of Science ®Google Scholar
• Beuth J, Ko H L, Tunggal L, Geisel J, Pulverer G. Comparative studies on the immunoactive action of galactoside-specific mistletoe lectin. Pure substance compared to the standardized extract. Arzneimittelforschung 1993; 43: 166
   Google Scholar
• Bocci V. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review. J Biol Regul Homeost Agents 1993; 7: 1
   PubMed Web of Science ®Google Scholar
• Bantel H, Engels I H, Voelter W, Schulze-Osthoff K, Wesselborg S. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res. 1999; 59: 2083
   PubMed Web of Science ®Google Scholar
• Kubasova T, Petcu I, Pfuller U, Koteles G J. Effects of mistletoe lectin I and ionizing radiation on the glucose and thymidine uptake in tumour cells in vitro. Phytother Res. 1999; 13: 655
   Google Scholar
• Minemura M, Tanimura H, Tabor E. Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines. Int J Oncol. 1999; 15: 559
   PubMed Web of Science ®Google Scholar
• Ravi D, Panikkar K R, Nair M K, Pillai M R. Apoptosis: future directions in cancer therapy. Natl Med J India 2000; 13: 71
   Google Scholar
• Pae H O, Yoo J C, Choi B M, Lee E J, Song Y S, Chung H T. 12-O-tetradecanoyl phorbol 13-acetate, protein kinase C (PKC) activator, protects human leukemia HL-60 cells from taxol-induced apoptosis: possible role for extracellular signal-regulated kinase. Immunopharmacol Immunotoxicol. 2000; 22: 61
   PubMed Web of Science ®Google Scholar
• Mannel R S, Blessing J A, Boike G. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: A phase II trial of the gynecologic oncology group. Gynecol Oncol. 2000; 79: 64
   Google Scholar
• Orlandi L, Zaffaroni N, Bearzatto A, Villa R, De Marco C, Silvestrini R. Lonidamine as a modulator of taxol activity in human ovarian cancer cells: effects on cell cycle and induction of apoptosis. Int J Cancer 1998; 78: 377
   PubMed Web of Science ®Google Scholar
• Gagandeep S, Novikoff P M, Ott M, Gupta S. Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines. Cancer Lett. 1999; 136: 109
   PubMed Web of Science ®Google Scholar
• Warrington R C, Fang W D, Zhang L U. L-histidinol reverses resistance to cisplatinum and other antineoplastics in a tumorigenic epithelial cell line. Anticancer Res. 1996; 16: 3641
   Google Scholar
• Warrington R C, Fang W D, Zhang L, Shieh M, Saier M H, Jr. L-histidinol selectively modulates daunomycin toxicity in normal and tumorigenic kidney epithelial cells. Anticancer Res. 1996; 16: 3629
   Google Scholar
• Warrington R C, Fang W D, Zhang L, Shieh M, Saier M H, Jr. Mimetics of L-histidinol which selectively modulate daunomycin toxicity in normal and tumorigenic epithelial cells. Anticancer Res. 1996; 16: 3635
   Google Scholar
• Warrington R C, Fang W D. Reversal of the multidrug-resistant phenotype of Chinese hamster ovary cells by L-histidinol. J Natl Cancer Inst. 1989; 81: 798
   Google Scholar
• Warrington R C, Cheng I, Zhang L, Fang W D. L-histidinol increases the vulnerability of cultured human leukemia and lymphoma cells to anticancer drugs. Anticancer Res. 1993; 13: 2107
   Google Scholar
• Warrington R C. L-histidinol in experimental cancer chemotherapy: improving the selectivity and efficacy of anticancer drugs, eliminating metastatic disease and reversing the multidrug-resistant phenotype. Biochem Cell Biol. 1992; 70: 365
   Google Scholar